MapLight Therapeutics (MPLT) Preferred Shares Issued (2025)

MapLight Therapeutics' (MPLT) quarterly Preferred Shares Issued came in at $200.0 million in Q4 2025, little changed quarter-over-quarter from $200.0 million in Q3 2025.

MapLight Therapeutics (MPLT) Preferred Shares Issued (2025) Analysis & Trends

MapLight Therapeutics has disclosed Preferred Shares Issued across 1 years of filings, most recently posting $200.0 million for Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares Issued (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 MapLight Therapeutics 248.88 Mn 248.88 Mn - 200.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 200.00 Mn
Dec 31, 2025 200.00 Mn
Sep 30, 2025 200.00 Mn
Sep 30, 2025 200.00 Mn